Reports
Sale
North America Stem Cell Assay Market Size, Share, Growth: By Product & Service: Flow Cytometers, Cell Imaging & Analysis Systems, Microelectrode Arrays, Automated Cell Counters, Kits; By Cell Type: Adult Stem Cells, Others; By Type; By Treatment; By Application; By End User; Regional Analysis; Supplier Landscape; 2024-2032
North America Stem Cell Assay Market Outlook
The North America stem cell assay market size was valued at USD 7.1 billion in 2023, driven by the increased investment in stem cell research in the region. The market is expected to grow at a CAGR of 10.08% during the forecast period of 2024-2032, with the values likely to rise from USD 7.8 billion in 2024 to USD 16.9 billion by 2032.
Key Takeaways
- In May 2023 , a study published in Cell Reports Medicine revealed that a cancer stem cell assay called ChemoID can accurately predict clinical outcomes in response to chemotherapy, improving the survival of patients with recurrent glioblastoma.
- In April 2023, Discovery Life Sciences acquired ReachBio Research Labs to expand its offerings in drug discovery and preclinical development by leveraging ReachBio’s expertise in primary cell biology, particularly blood and bone marrow stem cell assays.
- According to the American Cancer Society, it is estimated that 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States in 2024.
Stem cell assay is a laboratory technique that helps to evaluate the behavior and function of stem cells. These assays find their applications in studying stem cell biology and assessing their potential therapeutic use. The rising cases of various chronic diseases in the region such as cancer are expected to directly impact the demand for novel treatment options, thereby driving the North America stem cell assay market growth. For instance, according to the American Cancer Society, it is estimated that 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States in 2024. Further, increased applications of stem cell assays in drug discovery and regenerative medicine are likely to augment the market size in the forecast period.
In North America, the rising impetus for stem cell research is resulting in advancements in stem cell assay methods and therapies. The development of innovative methods is expected to boost North America stem cell assay market demand as they can assist healthcare professionals in personalizing chemotherapy selection for cancer patients and in identifying the most effective therapy for each patient. In May 2023 , a study published in Cell Reports Medicine revealed that a cancer stem cell assay called ChemoID can accurately predict clinical outcomes in response to chemotherapy, improving the survival of patients with recurrent glioblastoma. In the randomized trial, the group guided by the ChemoID assay showed a median survival of 12.5 months, compared to 9 months in the physician-choice group. These findings offer a promising approach to providing more affordable treatment for patients with recurrent glioblastoma in lower socioeconomic groups in the United States.
North America stem cell assay market share is likely to be impacted by increased merger and acquisition initiatives among the key market players. In April 2023, a United States-based company specializing in biospecimen, biomarker, and proteogenomics Discovery Life Sciences acquired ReachBio Research Labs, a life sciences company based in Seattle known for their cell-based assays, drug screening services, and predictive hematotoxicity. The acquisition will enable Discovery Life Science to expand its offerings in drug discovery and preclinical development by leveraging ReachBio’s expertise in primary cell biology, particularly blood and bone marrow stem cell assays. The growing number of such strategic partnerships is anticipated to accelerate market growth in the coming years.
Other factors that fuel the market growth are the advancements in stem cell technologies resulting in enhanced efficiency and throughput of stem cell assays, increased healthcare expenditure, and rising funding for stem cell-based research. Further, the growing demand for personalized medicine and precision therapies will accelerate the market growth in the region.
North America Stem Cell Assay Market Segmentation
“North America Stem Cell Assay Market Report and Forecast 2024-2032” offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Product & Service | Flow Cytometers, Cell Imaging & Analysis Systems, Microelectrode Arrays, Automated Cell Counters, Kits |
| Cell Type | Adult Stem Cells, Human Embryonic Stem Cells, Pluripotent |
| Type | Viability/Cytotoxicity Assays, Isolation & Purification Assays, Cell Identification Assays, Proliferation Assays, Differentiation Assays, Function Assays, Apoptosis Assays, Others |
| Treatment | Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy, Syngeneic Stem Cell Therapy |
| Application | Regenerative Medicine & Therapy Development, Drug Discovery & Development, Clinical Research, Others |
| End User | Biopharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others |
| Countries | United States of America, Canada |
North America Stem Cell Assay Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific
- Perkinelmer
- Stemcell Technologies
- Merck
- Bio-Rad Laboratories
- Agilent Technologies
- Promega
- Bio-Techne
- Cell Biolabs
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product & Service |
|
| Breakup by Cell Type |
|
| Breakup by Type |
|
| Breakup by Treatment |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 North America Stem Cell Assay Market Overview
3.1 North America Stem Cell Assay Market Historical Value (2017-2023)
3.2 North America Stem Cell Assay Market Forecast Value (2024-2032)
4 North America Stem Cell Assay Market Landscape*
4.1 North America Osmometers: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 North America Osmometers: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Cell Type
4.2.3 Analysis by Treatment
5 North America Stem Cell Assay Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 North America Stem Cell Assay Market Segmentation (2017-2032)
6.1 North America Stem Cell Assay Market (2017-2032) by Product & Service
6.1.1 Market Overview
6.1.2 Flow Cytometers
6.1.3 Cell Imaging & Analysis Systems
6.1.4 Microelectrode Arrays
6.1.5 Automated Cell Counters
6.1.6 Kits
6.2 North America Stem Cell Assay Market (2017-2032) by Cell Type
6.2.1 Market Overview
6.2.2 Adult Stem Cells
6.2.3 Human Embryonic Stem Cells
6.2.4 Pluripotent
6.3 North America Stem Cell Assay Market (2017-2032) by Type
6.3.1 Market Overview
6.3.2 Viability /Cytotoxicity Assays
6.3.3 Isolation & Purification Assays
6.3.4 Cell Identification Assays
6.3.5 Proliferation Assays
6.3.6 Differentiation Assays
6.3.7 Function Assays
6.3.8 Apoptosis Assays
6.3.9 Others
6.4 North America Stem Cell Assay Market (2017-2032) by Treatment
6.4.1 Market Overview
6.4.2 Allogeneic Stem Cell Therapy
6.4.3 Autologic Stem Cell Therapy
6.4.4 Syngeneic Stem Cell Therapy
6.5 North America Stem Cell Assay Market (2017-2032) by Application
6.5.1 Market Overview
6.5.2 Regenerative Medicine &Therapy Development
6.5.3 Drug Discovery & Development
6.5.4 Clinical Research
6.5.5 Others
6.6 North America Stem Cell Assay Market (2017-2032) by End User
6.6.1 Market Overview
6.6.2 Biopharmaceutical & Biotechnology Companies
6.6.3 Academic & Research Institutes
6.6.4 Others
6.7 North America Stem Cell Assay Market (2017-2032) by Countries
6.7.1 Market Overview
6.7.2 United States of America
6.7.3 Canada
7 United States of America of Stem Cell Assay Market (2017-2032)
7.1 United State of America Stem Cell Assay Market (2017-2032) by Product & Service
7.1.1 Market Overview
7.1.2 Flow Cytometers
7.1.3 Cell Imaging & Analysis Systems
7.1.4 Microelectrode Arrays
7.1.5 Automated Cell Counters
7.1.6 Kits
7.2 United States of America Stem Cell Assay Market (2017-2032) by Cell Type
7.2.1 Market Overview
7.2.2 Adult Stem Cells
7.2.3 Human Embryonic Stem Cells
7.2.4 Pluripotent
7.3 United States of America Stem Cell Assay Market (2017-2032) by Type
7.3.1 Market Overview
7.3.2 Viability /Cytotoxicity Assays
7.3.3 Isolation & Purification Assays
7.3.4 Cell Identification Assays
7.3.5 Proliferation Assays
7.3.6 Differentiation Assays
7.3.7 Function Assays
7.3.8 Apoptosis Assays
7.3.9 Others
7.4 United State of America Stem Cell Assay Market (2017-2032) by Treatment
7.4.1 Market Overview
7.4.2 Allogeneic Stem Cell Therapy
7.4.3 Autologic Stem Cell Therapy
7.4.4 Syngeneic Stem Cell Therapy
7.5 United State of America Stem Cell Assay Market (2017-2032) by End User
7.5.1 Market Overview
7.5.2 Biopharmaceutical & Biotechnology Companies
7.5.3 Academic & Research Institutes
7.5.4 Others
7.6 United State of America Stem Cell Assay Market (2017-2032) by Application
7.6.1 Market Overview
7.6.2 Regenerative Medicine &Therapy Development
7.6.3 Drug Discovery & Development
7.6.4 Clinical Research
7.6.5 Others
8 Canada Stem Cell Assay Market (2017-2032)
8.1 Canada Stem Cell Assay Market (2017-2032) by Product & Service
8.1.1 Market Overview
8.1.2 Flow Cytometers
8.1.3 Cell Imaging & Analysis Systems
8.1.4 Microelectrode Arrays
8.1.5 Automated Cell Counters
8.1.6 Kits
8.2 Canada Stem Cell Assay Market (2017-2032) by Cell Type
8.2.1 Market Overview
8.2.2 Adult Stem Cells
8.2.3 Human Embryonic Stem Cells
8.2.4 Pluripotent
8.3 Canada Stem Cell Assay Market (2017-2032) by Type
8.3.1 Market Overview
8.3.2 Viability /Cytotoxicity Assays
8.3.3 Isolation & Purification Assays
8.3.4 Cell Identification Assays
8.3.5 Proliferation Assays
8.3.6 Differentiation Assays
8.3.7 Function Assays
8.3.8 Apoptosis Assays
8.3.9 Others
8.4 Canada Stem Cell Assay Market (2017-2032) by Treatment
8.4.1 Market Overview
8.4.2 Allogeneic Stem Cell Therapy
8.4.3 Autologic Stem Cell Therapy
8.4.4 Syngeneic Stem Cell Therapy
8.5 Canada Stem Cell Assay Market (2017-2032) by End User
8.5.1 Market Overview
8.5.2 Biopharmaceutical & Biotechnology Companies
8.5.3 Academic & Research Institutes
8.5.4 Others
8.6 Canada Stem Cell Assay Market (2017-2032) by Application
8.6.1 Market Overview
8.6.2 Regenerative Medicine &Therapy Development
8.6.3 Drug Discovery & Development
8.6.4 Clinical Research
8.6.5 Others
9 Regulatory Framework
10 Patent Analysis
10.1 Analysis by Type of Patent
10.2 Analysis by Publication year
10.3 Analysis by Issuing Authority
10.4 Analysis by Patent Age
10.5 Analysis by CPC Analysis
10.6 Analysis by Patent Valuation
10.7 Analysis by Key Players
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 Thermo Fisher Scientific
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 Perkinelmer
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 Stemcell Technologies
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Merck
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 Bio-Rad Laboratories
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Agilent Technologies
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 Promega
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 Bio-Techne
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 Cell Biolabs
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic Reach and Achievements
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
14 United States of America Cannula Market – Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 7.1 billion in 2023 driven by the increased investment in stem cell research in the region.
The market is anticipated to grow at a CAGR of 10.08% during the forecast period of 2024-2032, likely to reach a market value of USD 16.9 billion by 2032.
The growing prevalence of chronic diseases and the rising healthcare expenditure are fuelling the demand for the market.
One of the significant trends in the market is the increased merger and acquisition initiatives among the key market players. In April 2023, Discovery Life Sciences acquired ReachBio Research Labs, a life sciences company based in Seattle known for its cell-based assays, drug screening services, and predictive hematotoxicity.
Based on the product and services, the market is segmented into flow cytometers, cell imaging and analysis systems, microelectrode arrays, automated cell counters, and kits.
Treatments available in the market include allogeneic stem cell therapy, autologous stem cell therapy, and syngeneic stem cell therapy.
By type, the market is divided into viability/cytotoxicity assays, isolation and purification assays, cell identification assays, proliferation assays, differentiation assays, function assays, and apoptosis assays, among others.
The market breakup by cell type includes adult stem cells, human embryonic stem cells, and pluripotent.
End users of the market are biopharmaceutical and biotechnology companies, as well as academic and research institutes, among others.
Major applications areas of stem cell assays include regenerative medicine and therapy development, drug discovery and development, along with clinical research, among others.
The market segmentation by countries includes the United States of America and Canada.
The key market players include Thermo Fisher Scientific, PerkinElmer, Stemcell Technologies, Merck, Bio-Rad Laboratories, Agilent Technologies, Promega, Bio-Techne, and Cell Biolabs.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER